Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF (NY:JGRO)

91.20 -1.33 (-1.44%)
Streaming Delayed Price Updated: 2:56 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF

< Previous 1 2 3 Next >
News headline image
Amazon Reaches $2.5 Billion Settlement With FTC Over Prime Subscription Case: Report ↗
According to a CNBC report, the agreement comes at a time when the company and the FTC were three days into the trial in a Seattle courtroom, with opening arguments having been made on Tuesday. 
Via Stocktwits
Eli Lilly Terminates Study Of Bimagrumab In Obesity ↗
Via Stocktwits
Eli Lilly Announces Plan To Construct New $6.5B Facility In Texas ↗
Via Stocktwits
News headline image
Amazon To Close Its ‘Amazon Fresh UK’ Stores ↗
Amazon announced that it would offer redeployment opportunities to as many affected employees as possible following the closure of its Fresh stores. 
Via Stocktwits
Amazon Faces FTC In Trial Over Alleged Prime Enrollment Strategy: Report ↗
Via Stocktwits
News headline image
Meta’s Chief Product Officer Has An Interesting Take On Smart Glasses – More Details Inside ↗
In an interview with CNBC, Cox stated that humans communicate with them, they see with them, and use gestures in the same way they interact with each other to interact with computers. 
Via Stocktwits
Uber Inks Partnership With Flytrex For Drone Delivery In US: Retail Sees Stock ‘Going Higher For Longer’ ↗
Via Stocktwits
Amazon Rejigs AI Assistant For Online Sellers: Report ↗
Via Stocktwits
Topics Artificial Intelligence
Amazon Stock Received A Price Target Hike From Truist – Here’s Why ↗
Via Stocktwits
News headline image
McDonald’s Stock Edges Higher After Citigroup Boosts Price Target ↗
Citigroup said that it views McDonald's value price initiatives, easy comparisons, and potential for multiple expansion as reasons to own the stock. 
Via Stocktwits
Hims & Hers Stock Draws Investor Attention After Tumbling 7% – Here’s What Happened ↗
Via Stocktwits
Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside ↗
Via Stocktwits
Eli Lilly, Novo Nordisk Preparing To Introduce Obesity Pills Next Year In The US: Report ↗
Via Stocktwits
US FTC Probes Amazon, Google Over Search Advertising Practices: Report ↗
Via Stocktwits
AbbVie Stock Touches Record High After Company Dismisses Generic Competition For Rinvoq Till 2037: Wells Fargo Terms It A ‘Big Win’ ↗
Via Stocktwits
GE Vernova To Sell Proficy Software Unit To TPG For $600M ↗
Via Stocktwits
This Pharma Giant Is Set To Invest $2B To Expand Manufacturing In North Carolina, And It Just Received A Price Target Hike From Citi: Do You Own It? ↗
Via Stocktwits
Apple Plans Tabletop Robot, Among Other AI Products, Says Report ↗
Via Stocktwits
Topics Artificial Intelligence
Gilead Stock Showered With Upgrades, Price Target Hikes After Upbeat Q2, Guidance Lift: Retail’s Turned Exuberant ↗
Via Stocktwits
News headline image
Hims & Hers Stock Rises After Company Launches Treatment Plans For Low Testosterone ↗
According to Stocktwits data, retail chatter around HIMS stock increased by 21% over the last 24 hours and by approximately 533% over the last 30 days as of the early hours on Wednesday. 
Via Stocktwits
News headline image
Eli Lilly Launches AI, Machine Learning Platform Called TuneLab For Biotech Companies ↗
The platform will provide biotech companies access to drug discovery models trained on years of Lilly's research data, the company stated. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Eli Lilly To Hike Mounjaro Prices By A Whopping 170% In UK: Retail Expects Stock To See Smooth Rally Till $720 ↗
According to the Financial Times, the price for a month’s supply of the highest doses of the drug will rise from £122 to £330, an increase of 170%. 
Via Stocktwits
Topics Government World Trade
News headline image
HC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of Week ↗
The analyst sees Insmed as "poised to join the ranks" of Roche's Genentech and Pfizer's Seagen as companies that have successfully deployed the "pipeline-in-a-pill" strategy. 
Via Stocktwits
US Regulator Grants Exemption For Zoox Vehicles To Be On Road Without Compliance With Federal Standards ↗
Via Stocktwits
News headline image
Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance ↗
Texas Attorney General Ken Pax­ton alleged that Lilly offered illegal incentives to medical providers in Texas designed to steer providers toward prescribing Lilly’s drugs. 
Via Stocktwits
Topics Fraud Law Enforcement Lawsuit
News headline image
BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive ↗
The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting... 
Via Stocktwits
News headline image
Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet ↗
Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday. 
Via Stocktwits
Topics Workforce
News headline image
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours ↗
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
AbbVie Enters Licensing Agreement For IGI Therapeutics’ Experimental Oncology Drug: Retail Cheers ↗
Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. 
Via Stocktwits
Topics Product Recall
News headline image
Intuitive Surgical Gets FDA Clearance For Advanced Energy Surgical Instrument: Retail Sentiment Improves ↗
Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue for use with Intuitive’s da Vinci surgical systems. 
Via Stocktwits
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.